Name: Net Profit Margin

Definition: Net profit margin shows how much profit remains after paying all costs — including operating expenses, interest, and taxes — for every dollar of sales. A higher margin means the business is efficient and keeps more of its sales as bottom-line profit. Falling margins may signal rising costs or pricing pressure.

Interpretation:
• In '2021', MASI's net profit margin was 18.5%, measuring the overall profitability of the company. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2021' stood at -58.2%.
• In '2022', MASI's net profit margin was 7.0%, measuring the overall profitability of the company. The decline from '2021' may indicate some operational or financial challenges. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2022' stood at -66.1%. Industry average declined by 7.9% from previous year.
• In '2023', MASI's net profit margin was 4.0%, measuring the overall profitability of the company. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2023' stood at -81.4%. Industry average declined by 15.3% from previous year.
• In '2024', MASI's net profit margin was -14.6%, measuring the overall profitability of the company. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Electromedical & Electrotherapeutic Apparatus in '2024' stood at -67.4%. Industry average increased by 14.1% compared to previous year.
Overall, MASI's net profit margin has been volatile but showed a downward trend over the past 4 years.

Formula: Net Profit Margin = Net Income / Revenue

Good Range: Ranges 5%-20% for many industries.